Cervical cancer (cervical cancer) is the second most frequent cause of death from malignant neoplasm among women in the world, second only to breast cancer. According to the International Agency for Research on Cancer, in 2002 there were 493,000 new cases of cervical cancer and 274,000 deaths from it [Parkin D. et al. , 2005].

In Russia, in 2004, 12,377 patients were registered with a diagnosis of cervical cancer. Despite visual localization, cervical III-IV stages were detected in 39.5% of patients. High mortality remains during the first year from the moment of diagnosis (20.8%), which indicates late diagnosis and not always adequate treatment [Chisov B. with co-workers. , 2005].

It should be noted that cervical cancer is the only one of the malignant diseases of reproductive organs in women, which currently only clinically develops. The staging is based on the clinical criteria of the International Federation of Gynecologists and Obstetricians (FIGO), which includes data from physical examination, colposcopy, biopsy of education, radiotherapy (radiography, intravenous urography) and endoscopic studies (cystoscopy, sigmoidoscopy).

At present, the possibilities of integrated diagnostics have expanded due to the introduction of new medical technologies (echography, magnetic resonance imaging (MRI), X-ray computed tomography (RKT)). A new method used in the diagnosis of cervical cancer is three-dimensional sonography. With the use of color or energy Doppler mapping, the blood flow in the tumor can be assessed, while, in contrast to the two-dimensional Doppler sonography, vascularization of the entire tumor. Three-dimensional sonography with dopplerography can be used to evaluate the effectiveness of chemoradiotherapy for cervical cancer, excluding the need for MPT health. sumy. ua.